[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@medtechmd Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::329402736.png) @medtechmd Will

Will posts on X about $kura, $lnth, $xene, target the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::329402736/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::329402736/c:line/m:interactions.svg)

- X Week XXXXX +316%
- X Month XXXXXX -XX%
- X Months XXXXXXX -XX%
- X Year XXXXXXX +155%

### Mentions: XX [#](/creator/twitter::329402736/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::329402736/c:line/m:posts_active.svg)

- X Week XX no change
- X Month XX -XX%
- X Months XXX -XXXX%
- X Year XXX +85%

### Followers: XXX [#](/creator/twitter::329402736/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::329402736/c:line/m:followers.svg)

- X Week XXX +0.72%
- X Month XXX +3.10%
- X Months XXX +13%
- X Year XXX +48%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::329402736/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::329402736/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[travel destinations](/list/travel-destinations)  XXX% [stocks](/list/stocks)  XXX%

**Social topic influence**
[$kura](/topic/$kura) #6, [$lnth](/topic/$lnth) 14.81%, [$xene](/topic/$xene) #2, [target](/topic/target) 11.11%, [$gehc](/topic/$gehc) 7.41%, [london](/topic/london) 3.7%, [$1b](/topic/$1b) 3.7%, [future](/topic/future) 3.7%, [morgan stanley](/topic/morgan-stanley) 3.7%, [$tmdx](/topic/$tmdx) XXX%

**Top accounts mentioned or mentioned by**
[@drtanwp](/creator/undefined) [@jamiespakand](/creator/undefined) [@nyulangone](/creator/undefined) [@focalonehifu](/creator/undefined) [@benioff](/creator/undefined) [@amarukishan](/creator/undefined)

**Top assets mentioned**
[Lantheus Holdings, Inc (LNTH)](/topic/$lnth) [Xenon Pharmaceuticals Inc (XENE)](/topic/$xene) [GE HealthCare Technologies Inc. Common Stock (GEHC)](/topic/$gehc) [Morgan Stanley (MS)](/topic/morgan-stanley) [TransMedics Group, Inc. Common Stock (TMDX)](/topic/$tmdx)
### Top Social Posts
Top posts by engagements in the last XX hours

"Jefferies comments from London Conference regarding $GEHC & Flyrcado of which $LNTH receives royalties: We view Flyrcado as one of the most significant growth drivers for GEHC projecting sales $1B by 2028 above guidance and cons"  
[X Link](https://x.com/medtechmd/status/1990758259008156012)  2025-11-18T12:25Z XXX followers, XXX engagements


"Jefferies commentary $KURA Ziftomenib vs competitor. Price Target $XXXXX. Ziftos once-daily dosing absence of clinically meaningful DDI and cleaner combinability position it better for sequencing with VEN/AZA FLT3 inhibitors and future triplets"  
[X Link](https://x.com/medtechmd/status/1991355214558032133)  2025-11-20T03:57Z XXX followers, 5363 engagements


"Morgan Stanley Underestimates $TMDX Role In Transforming The Organ Transplant Dynamic In The US And Abroad"  
[X Link](https://x.com/medtechmd/status/1995822091292017027)  2025-12-02T11:47Z XXX followers, 2683 engagements


"Jefferies latest comments on $KURA & competitive landscape with data due at ASH 2025"  
[X Link](https://x.com/medtechmd/status/1995923465237659836)  2025-12-02T18:30Z XXX followers, XXX engagements


"$LNTH PNT2002 Along W/Stereotactic Body Radiotherapy Resulted In Significantly Improved PFS In Recurrent Prostate Cancer"  
[X Link](https://x.com/medtechmd/status/1997728350388002953)  2025-12-07T18:02Z XXX followers, XXX engagements


"With earlier approval $KURA is ready to launch within days only 2-3wks behind key comp and expects to take sig market share based on favorable overall profile/FDA label and market research"  
[X Link](https://x.com/medtechmd/status/1989071563870888022)  2025-11-13T20:43Z XXX followers, 12.8K engagements


"Jefferies comments regarding $XENE & $RAPP for data/presentations at American Epilepsy Society 12/5-9"  
[X Link](https://x.com/medtechmd/status/1994756963444691402)  2025-11-29T13:14Z XXX followers, XXX engagements


"$XENE Azetukalner Continues Excellent Safety & Efficacy Advantages In X Year Focal Epilepsy Indication"  
[X Link](https://x.com/medtechmd/status/1997831536385663449)  2025-12-08T00:52Z XXX followers, XXX engagements


"Jefferies Maintains $XXX Price Target On $LNTH"  
[X Link](https://x.com/medtechmd/status/1986511182652711077)  2025-11-06T19:09Z XXX followers, XXX engagements


"Positive comments from RSNA Regarding $LNTH Pylarify & $GEHC/$LNTH Flyrcado"  
[X Link](https://x.com/medtechmd/status/1996181197651911070)  2025-12-03T11:34Z XXX followers, XXX engagements


"$XENE Showcases New 48-Month Azetukalner OLE Study Data in Epilepsy at AES 2025. Monthly reductions in seizure frequency of XXXX% among participants treated for XX months in the OLE with XX% achieving X year of seizure freedom"  
[X Link](https://x.com/medtechmd/status/1996948155347116064)  2025-12-05T14:21Z XXX followers, XXX engagements


"$KURA : $XXXXX Price Target"  
[X Link](https://x.com/medtechmd/status/1992943174416036251)  2025-11-24T13:07Z XXX followers, 1055 engagements


"$XENE Four Year Data Focal Epilepsy: Jefferies Comments Post AES"  
[X Link](https://x.com/medtechmd/status/1997832099639046150)  2025-12-08T00:54Z XXX followers, XXX engagements